First‐line immune checkpoint therapy in metastatic squamous cell lung cancer harboring both EGFR mutation and high expression of PD‐L1: A case report

por Hamai, Kosuke, Tanahashi, Hiroki, Ueno, Sayaka, Konishi, Hanae, Matsumura, Mirai, Nomura, Akio, Nakamoto, Kanako, Isoyama, Shoko, Tanimoto, Takuya, Shoda, Hiroyasu, Ishikawa, Nobuhisa
Publicado 2020

Switching Treatment from Mepolizumab to Benralizumab for Elderly Patients with Severe Eosinophilic Asthma: A Retrospective Observational Study

por Isoyama, Shoko, Ishikawa, Nobuhisa, Hamai, Kosuke, Matsumura, Mirai, Kobayashi, Hiroki, Nomura, Akio, Ueno, Sayaka, Tanimoto, Takuya, Maeda, Hiroyuki, Iwamoto, Hiroshi, Hattori, Noboru
Publicado 2022

Effect of baricitinib in patients with coronavirus disease 2019 and respiratory failure: A propensity score-matched retrospective cohort study

por Tanimoto, Takuya, Tada, Shinpei, Fujita, Suguru, Hirakawa, Tetsu, Matsumura, Mirai, Isoyama, Shoko, Ueno, Sayaka, Hamai, Kosuke, Tsuji, Naoki, Hirosawa, Hideyasu, Taniguchi, Tomohiro, Okamoto, Takeshi, Omoto, Takuji, Kusunoki, Shinji, Maeda, Hiroyuki, Ishikawa, Nobuhisa
Publicado 2022

Phase 2 study of first‐line pembrolizumab monotherapy in elderly patients with non‐small‐cell lung cancer expressing high PD‐L1

por Masuda, Takeshi, Fujitaka, Kazunori, Suzuki, Tomoko, Hamai, Kosuke, Matsumoto, Naoko, Matsumura, Mirai, Isoyama, Shoko, Ueno, Sayaka, Mito, Mineyo, Yamaguchi, Kakuhiro, Sakamoto, Shinjiro, Kawano, Reo, Masuda, Ken, Nishino, Ryohei, Ishikawa, Nobuhisa, Yamasaki, Masahiro, Hattori, Noboru
Publicado 2022